Andrew Feigin

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Adeno-associated Virus, Medical Treatment, Borne Gad Gene +4

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 661 citations

Advanced Parkinson, Aav2-gad Gene Therapy, Neurological Progress +5

FDG PET in the differential diagnosis of parkinsonian disorders

Thomas Eckert, Anna Barnes, Vijay Dhawan et al. · NeuroImage · 2005 · 419 citations

Neurological Disorder, Parkinson Disease, Neuroscience +4

Changes in network activity with the progression of Parkinson's disease

Chaorui Huang, Chengke Tang, Andrew Feigin et al. · Brain · 2007 · 390 citations · Full text

Longitudinal Changes, Social Sciences, Network Activity +20

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

Chris C. Tang, Kathleen L. Poston, Thomas Eckert et al. · The Lancet Neurology · 2010 · 348 citations · Full text

Neuroimaging Biomarkers, Neuroimaging Modality, Parkinson Disease +11